MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, ...

Oral GLP-1 RA peptide program clinical trial initiated Metsera has initiated a clinical trial ... and candidates targeting other complementary NuSH pathways, including glucagon and PYY, as well as ...